Recent News

• 05.06.2025 - Day One Biopharmaceuticals Q1 2025 Earnings Conference Call
• 04.23.2025 - Giving New Life to Medicines – and New Options to Patients Fighting Cancer
• 04.22.2025 - Day One to Report First Quarter 2025 Financial Results Tuesday, May 6, 2025
• 03.04.2025 - 45th Annual TD Cowen Health Care Conference
• 02.25.2025 - Day One Biopharmaceuticals Q4 and Full Year 2024 Earnings Conference Call
• 02.25.2025 - Day One Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Progress

Recent Filings

• 04.11.2025 - ARS Annual Report to Security Holders
• 04.11.2025 - DEF 14A Other definitive proxy statements
• 04.11.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 03.06.2025 - 10-K/A Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.28.2025 - 3 Initial statement of beneficial ownership of securities
• 02.25.2025 - EX-99.1 EX-99.1
• 02.25.2025 - 8-K Current report
• 02.25.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.21.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.21.2025 - 4 Statement of changes in beneficial ownership of securities